Will Lewis, Insmed CEO, joins 'Fast Money' to discuss the company's lung drug being greenlit by the FDA and what it means for ...

PureTech Health has launched a subsidiary company – Celea Therapeutics – with the task of taking an experimental drug for ...

The Guam Department of Public Health and Social Services has confirmed an uptick in respiratory viral activity on the island, ...

A 28-year-old woman was admitted to the hospital because of severe hypoxemia and right heart failure that had been caused by rapidly progressive pulmonary hypertension. A diagnosis was made.

As if there aren't enough warnings about the dangers of vaping, now comes a new study that says a majority of the mouthpieces ...

In an increasingly challenging environment for scientific research funding, the American Lung Association Research Institute today announced the opening of its 2026-2027 Research Awards and Grants ...

Insmed received FDA clearance for the first treatment for a chronic lung disease, opening the way to what could be a ...

Palivizumab was the only approved therapy to prevent severe RSV disease in infants and young children until the approval of nirsevimab in 2023.

In its second-quarter earnings release, the company said that in July and August 2025 it analyzed interim data from the ...

The FDA has approved Insmed’s brensocatib, the first treatment for non-cystic fibrosis bronchiectasis, a chronic and progressive lung disease affecting about 500,000 people in the U.S. The drug was ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...